Advantages of Real-Time Three-Dimensional Echocardiography Over Two-Dimensional Echocardiography by Aggeli, Constantina et al.
Advantages of Real-Time  
Three-Dimensional Echocardiography 
Over Two-Dimensional Echocardiography
Constantina Aggeli, MD, Ioannis Felekos, MD,  
Christodoulos Stefanadis, MD
I N T R O D U C T I O N
Over the last fifty-years conventional two-dimensional (2D) echocardiography has 
served as a valuable clinical adjunct for the diagnosis and management of cardiovas-
cular disease. However, the echocardiologist was expected to mentally reconstruct the 
complex structure of myocardium, resulting in geometrical assumptions which in turn 
could underestimate the validity of clinical findings.
Three-dimensional (3D) echocardiographic (3DE) imaging represents a major 
innovation in cardiovascular imaging. The usefulness of 3D-echocardiography has 
been summarized mainly in (a) the evaluation of cardiac chamber volumes and mass, 
avoiding geometric assumptions; (b) the assessment of regional left ventricular (LV) 
wall motion; (c) presentation of realistic views of heart valves; (d) volumetric assess-
ment of regurgitant lesions and shunts with 3D color Doppler imaging; and (e) 3D 
stress imaging. It’s worth noting that both beginners and experts benefit from 3DE, 
since image acquisition has been simplified and accelerated. In addition, concerning 
inter-observer variability, 3DE offers significant improvement.
Recent technological advancements have rendered this technique feasible both 
in the echocardiography and the catheterization laboratories for a variety of clinical 
applications.1 All these improve the way clinicians perceive cardiac structure and its 
spatial relationship with other organs. For 3D echocardiography to be efficiently im-
plemented in routine clinical practice, a full understanding of its technical principles 
and a systematic approach to image acquisition and analysis are required.
E V A L U A T I O N  O F  C A R D I A C  C H A M B E R  V O L U M E S
The initially explored and most common clinical application of 3DE is the quan-
titative evaluation of cardiac chamber dimensions and volumes. A firmly established 
advantage of 3DE imaging over cross-sectional slices of the heart is the improvement 
in the accuracy of the evaluation of LV volumes and ejection fraction by eliminating 
the need for geometric modeling, which is inaccurate in the presence of aneurysms, 
asymmetrical ventricles, or wall motion abnormalities. This novel modality is able to 
depict the whole extent of the left ventricle, allowing accurate off-line assessment of 
LV mass and volumes with the implementation of dedicated software. The results 
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have been validated with magnetic resonance imaging (MRI) 
which is regarded as the standard of reference.2 Additionally, 
the complex crescent like morphology of the right ventricle 
can be assessed and quantified, providing valuable infor-
mation in various disease sates including congenital heart 
disease.3 Theoretically, the intrinsic ability of 3DE imaging 
to directly measure right ventricular volumes without the 
need for geometric modeling could be expected to result in 
improved accuracy and reproducibility compared with tradi-
tional 2DE measurements. The left atrium is a structure whose 
volume alterations have prognostic implications. However, 2D 
echocardiography systematically underestimates volumes. On 
the other hand, 3DE offers more accurate measurements as 
compared to MRI.4 Recent advances on 3DE have focused on 
specific software of each particular chamber resulting in more 
accurate evaluation of shape and function.
A S S E S S M E N T  O F  R E G I O N A L  w A L L -
M O T I O N  A B N O R M A L I I T I E S
Real-time three-dimensional echocardiography has the 
inherent advantage of obtaining information in a full-volume 
pyramidal dataset within a single acquisition. This translates 
into clinical practice since the operator can obtain multiple 
views as deemed necessary which can illustrate regional wall 
motion abnormalities.5 That could assist in determining the 
extent of wall motion abnormality as well as in ruling out 
artifacts frequently noted in standard imaging planes due to 
limited endocardial visualization. Moreover, conventional 
2D echocardiography requires significant experience in im-
age acquisition, while 3DE can provide information even by 
an inexperienced user. Recently, myocardial perfusion with 
3DE has become possible with the implementation of contrast 
agents (Figure 1).6 On the other hand, there are important 
limitations including low temporal and spatial resolution that 
limit the diagnostic value of 3DE. These limitations are ex-
pected to be overcome with evolution in transducer technology.
E V A L U A T I O N  O F  A T H E R O S C L E R O S I S
Research and clinical interest has recently focused on 
the 3DE evaluation of atherosclerosis of the carotid artery 
and aorta.7 Novel modalities have rendered the volumetric 
assessment of atheromatous burden a reality, enabling the 
quantification of atherosclerosis. The evaluation of extension 
of atherosclerotic disease plays a crucial role in prognosis on 
various groups of patients with cardiovascular disease. Wheth-
er it is really a barometer before the storm remains to be seen.
A P P L I C A T I O N S  I N  I N T E R V E N T I O N A L 
C A R D I O L O G Y
Real-time three-dimensional echocardiography is now an 
indispensable resident in the catheterization laboratory, as it is 
applicable to a wide range of interventions. The interventional 
echocardiologist must be aware of the different implantation 
techniques before attempting to guide a procedure. Three-
dimensional transesophageal echocardiography (TEE) has 
been shown to provide additional insight into the anatomical, 
morphological and hemodynamic assessment of structural 
heart disease. It has become the imaging modality of choice 
for many interventionists, and in many cases it serves as the 
operator’s “eyes” to evaluate, guide, and assess the results of 
procedures in the catheterization laboratory. The unique struc-
tural information obtained offers the potential for shorter and 
safer interventional procedures, with a higher rate of technical 
success, thus improving patient outcomes.
VA LV U L A R  H E A R T  D I S E A S E
Using new technology with advanced matrix transducers, 
transthoracic 3D echocardiography provides more accurate 
morphological and functional information. It gives detailed 
data on definitive anatomical characterization (number of 
cusps or leaflets), and localization, enables planimetry of valve 
orifice and offers exact information on prosthetic valves with 
the trade-off of poorer overall imaging quality. Real-time 
3DE can guide the interventionist both in patient selection 
and during the transcatheter valve implantation.
With regards to the trans-catheter aortic valve implantation 
(TAVI), it is now possible to estimate the exact annulus size, 
avoiding any geometrical assumptions involving annular shape 
and geometry. The decision regarding the size of the prosthesis 
FIGURE 1. 3D echocardiography data set after off-line cropping 
illustrating apical perfusion defect in 4-chamber view
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may not always be easy due to the relationship between the 
complex aortic valve anatomy and the aortic root–LV outflow 
tract. In 3DE studies, it has been shown that the annulus is 
often not circular, but rather elliptical.8,9 Thus, more accurate 
valve size can be selected for each patient, avoiding complica-
tions related to valve under- or over-sizing. Various studies 
have validated this specific application of 3DE.10 Moreover, 
the exact definition of coronary ostia must be performed, 
especially for the Sapiens Edwards valve. There should be a 
minimum distance of 10–11 mm between the aortic annulus 
and the coronary ostium (particularly the left). In clinical 
practice, this measurement is performed by means of multislice 
computed tomography (CT) and it can also be determined 
with full volume 3D echocardiography.11,12 Furthermore 3DE 
can aid in the positioning and deployment of the prosthetic 
valve across the annulus and then assess whether there is any 
degree of aortic regurgitation.
In addition, 3DE plays an integral role for the transcatheter 
treatment of mitral valve regurgitation with the MitraClip 
device. The ability to illustrate the morphology of the complex 
mitral valve apparatus from the left atrial view (surgical view) 
has vastly improved our understanding of mitral valve pathol-
ogy. The clinician can now decide whether the regurgitation 
is due to degenerative or functional causes which can be cor-
rected with the MitraClip system. Moreover, the eccentricity of 
the regurgitant jet can be deferred, which is an important step 
during patient selection stage and evaluate if there is sufficient 
tissue for mechanical caption of the valve. Intra-procedurally 
3DE is very helpful during trans-septal puncture and facilitates 
catheter orientation towards the mitral valve apparatus.13
C L O S U R E  O F  PA R AVA LV U L A R  L E A K S  
A N D  I N T R A C A R D I A C  S H U N T S
Two-dimensional TEE has become an essential and inte-
gral tool of the interventional device closure, but it is limited 
in its ability to detect the position of a catheter or a device 
relative to its surrounding environment due to only two spa-
tial dimensions. Even in experienced operators, numerous 
cut planes are necessary in order to mentally reconstruct the 
anatomical setting. The application of 3DE was shown to be 
feasible for the accurate determination of atrial septal defect 
(ASD) size, shape, rims guiding patient and device selection 
and also demonstrated a decrease in fluoroscopy time. Real-
time 3D transesophageal echocardiography provides a novel 
imaging modality for the guidance of ASD and patent foramen 
ovale (PFO) closures, giving fast and complete information 
about the appropriate position of the device in its surround-
ing environment and assesses post-operatively the firm and 
complete implantation of the device (Figure 2).14
In paravalvular leak closure the main issue is to adequately 
visualize the leak(s) and assess its spatial relationship with 
surrounding structures. Real-time 3DE can offer enhanced 
appreciation of the complex anatomy. More importantly, 3DE 
FIGURE 3. Prosthetic mitral valve paravalvular leak closure de-
vice (blue arrow) as shown from left atrial view.
FIGURE 2. “Surgical” view depicting successful implantation of 
Amplatz ASD closure device. ASD = atrial septal defect.
can assess the presence of multiple leak sites with irregular 
shapes, which could affect the result of the intervention. It can 
also offer guidance during catheter steering and manipulation 
through the defect without the need for time-intensive offline 
reconstruction. In addition, 3D echocardiography can be used 
immediately post- closure (Figure 3) to assess device stability 
and interaction with surrounding structures.15
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C O N C L U S I O N
Real-time three-dimensional echocardiography is a fea-
sible technique offering a more comprehensive insight into 
structural heart disease. It vastly improves and expands the 
diagnostic capabilities of cardiac ultrasound in a manner that 
complements traditional 2D echocardiography. Furthermore, 
3DE allows visualization of cardiac anatomy and pathology in 
a format that is readily appreciated by cardiac surgeons, and 
is very helpful in guiding and assessing the results of interven-
tional procedures. It is currently applied in various clinical 
settings and in the future with the improvement in transducer 
technology it will be the standard of choice procedure.
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